Medicenna to Present at the 2023 Guggenheim Oncology Conference

January 31, 2023

https://www.globenewswire.com/news-release/2023/01/31/2598318/0/en/Medicenna-to-Present-at-the-2023-Guggenheim-Oncology-Conference.html

TORONTO and HOUSTON, Jan. 31, 2023 (GLOBE NEWSWIRE) — Medicenna Therapeutics Corp. (“Medicenna” or “the Company”) (NASDAQ:MDNA TSX:MDNA), a clinical stage immuno-oncology company, today announced that Dr. Fahar Merchant, President, CEO and Chairman of the Board of Medicenna, will participate in a fireside chat at the 2023 Guggenheim Oncology Conference, which is scheduled to take place from February 8 – 9, 2023.

Read more at globenewswire.com

Related news for (MDNA)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.